Skip to : [Content] [Navigation]
 

 

February 2003
Medical Device & Diagnostic Industry
Selected Contents



EDITOR'S PAGE:
In Pursuit of Failure


COVER STORY

Medical Device Design: The State of the Art
Stacey L. Bell

The trends and technologies that are influencing the design of today’s medical devices reflect an increased focus on  the end-user and home healthcare.

Sidebar: Medical Devices Go Green


CORPORATE OUTLOOK

Preparing for a World of Change
Gregg Nighswonger 

How are device manufacturers getting ready for technological change and new market factors? Four industry executives share their views.

Sidebar: Roundtable Participants

 



RISK MANAGEMENT

Establishing Overall Risk for Medical Devices

Mike W. Schmidt

In addition to reducing individual risks, device makers must develop an overall risk index in accordance with ISO/IEC 14971, Clause 7.


WASHINGTON WRAP-UP:
James G. Dickinson

McClellan Hits the Ground Running

The new FDA commissioner is demonstrating an impressive decisiveness and understanding of agency bureaucracy. A top priority is reduction of medical errors.

Plus:

  • Who Reviews Combination Products?
  • Bard Avoids Liability for Labeling
  • Uterine Fibroids Device Cleared
  • Stair-Climbing Wheelchair (pictured)
  • Carbon Dioxide Monitor Guidance
  • More Answers on Reprocessed Devices

NEWSTRENDS


R&D DIGEST:


PRODUCT DEVELOPMENT INSIGHT

Project Advisory Boards: Improving Product Development Quality and Consistency
Richard Rosen

Advisory boards enhance development efforts and help companies meet the ever-increasing challenges of developing and launching new products.



REGULATORY OUTLOOK

FDA’s Regulation of Analyte-Specific Reagents
Jeffrey K. Shapiro and Randy J. Prebula

Confusing and at times counterintuitive, the ASR rule applies to materials used in in-house-developed tests, not the assays themselves.